1. Home
  2. VTAK vs ATXG Comparison

VTAK vs ATXG Comparison

Compare VTAK & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.38

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

ATXG

Addentax Group Corp.

HOLD

Current Price

$0.27

Market Cap

4.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
ATXG
Founded
2002
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
4.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VTAK
ATXG
Price
$1.38
$0.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.8K
1.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
89.53
N/A
EPS
N/A
N/A
Revenue
$442,000.00
N/A
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$0.26
52 Week High
$4.31
$1.86

Technical Indicators

Market Signals
Indicator
VTAK
ATXG
Relative Strength Index (RSI) 36.38 31.08
Support Level $1.14 N/A
Resistance Level $2.05 $0.49
Average True Range (ATR) 0.12 0.03
MACD -0.01 -0.01
Stochastic Oscillator 16.67 9.65

Price Performance

Historical Comparison
VTAK
ATXG

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: